{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:27:30Z","timestamp":1772767650310,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":59,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PS148588"],"award-info":[{"award-number":["PS148588"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Immunology"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crimmu.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T07:09:00Z","timestamp":1646723340000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Loss of thymic function promotes EAE relapse in anti-CD52-treated mice"],"prefix":"10.1016","volume":"3","author":[{"given":"Adeolu O.","family":"Adegoke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-4237","authenticated-orcid":false,"given":"Colin C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crimmu.2022.03.001_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fimmu.2020.00056","article-title":"Event-driven immunoprofiling predicts return of disease activity in alemtuzumab-treated multiple sclerosis","volume":"11","author":"Akg\u00fcn","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211239","article-title":"Failures in thymus medulla regeneration during immune recovery cause tolerance loss and prime recipients for auto-GVHD","volume":"219","author":"Alawam","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.crimmu.2022.03.001_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/288389a0","article-title":"Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing","volume":"288","author":"Ben-Nun","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.crimmu.2022.03.001_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ni1049","article-title":"Continued maturation of thymic emigrants in the periphery","volume":"5","author":"Boursalian","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib4","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.4049\/jimmunol.0901576","article-title":"Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway","volume":"183","author":"Chen","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib5","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.crimmu.2022.03.001_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.0b013e31827b5927","article-title":"Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis","volume":"80","author":"Cossburn","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.crimmu.2022.03.001_bib8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.1601884","article-title":"Two strikes and you\u2019re out? The pathogenic interplay of coinhibitor deficiency and lymphopenia-induced proliferation","volume":"198","author":"Ellestad","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib9","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/eji.201444688","article-title":"PD-1 is not required for natural or peripherally induced regulatory T cells: severe autoimmunity despite normal production of regulatory T cells","volume":"44","author":"Ellestad","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1074-7613(00)80092-8","article-title":"The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery","volume":"11","author":"Ernst","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.crimmu.2022.03.001_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12974-020-01847-9","article-title":"Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis","volume":"17","author":"Gilmore","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.crimmu.2022.03.001_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/eji.201948288","article-title":"Anti-CD52 blocks EAE independent of PD-1 signals and promotes repopulation dominated by double-negative T cells and newly generated T and B cells","volume":"50","author":"Haile","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"The CAMPATH-1 antigen (CDw52)","volume":"35","author":"Hale","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.crimmu.2022.03.001_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp-2011-300826","article-title":"Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis","volume":"83","author":"Hill-Cawthorne","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.crimmu.2022.03.001_bib15","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1073\/pnas.1313654110","article-title":"Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation","volume":"110","author":"Jones","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.crimmu.2022.03.001_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.crimmu.2022.03.001_bib17","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1073\/pnas.1221955110","article-title":"Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery","volume":"110","author":"Paiva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.crimmu.2022.03.001_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.04.009","article-title":"Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis","volume":"165","author":"Pryce","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039416","article-title":"Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis","volume":"7","author":"Rao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.crimmu.2022.03.001_bib21","doi-asserted-by":"crossref","first-page":"16414","DOI":"10.3390\/ijms160716414","article-title":"Alemtuzumab in multiple sclerosis: mechanism of action and beyond","volume":"16","author":"Ruck","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crimmu.2022.03.001_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar1208","article-title":"Lymphopenia and autoimmune diseases","volume":"6","author":"Schulze-Koops","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.crimmu.2022.03.001_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.immuni.2012.08.008","article-title":"Subsets of nonclonal neighboring CD4+ T cells specifically regulate the frequency of individual antigen-reactive T cells","volume":"37","author":"Singh","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.crimmu.2022.03.001_bib24","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/eji.201343846","article-title":"T cells generated in the absence of a thoracic thymus fail to establish homeostasis","volume":"44","author":"Smolarchuk","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.1123497","article-title":"Evidence for a functional second thymus in mice","volume":"312","author":"Terszowski","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.crimmu.2022.03.001_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.1998.tb01211.x","article-title":"The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"164","author":"Tuohy","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.crimmu.2022.03.001_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jneuroim.2015.05.018","article-title":"Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis","volume":"285","author":"Turner","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1074-7613(00)80055-2","article-title":"Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition","volume":"10","author":"Viret","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.crimmu.2022.03.001_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/intimm\/13.6.763","article-title":"T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo","volume":"13","author":"Vivien","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.crimmu.2022.03.001_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/imm.12696","article-title":"Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis","volume":"150","author":"von Kutzleben","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.crimmu.2022.03.001_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-065X.1996.tb00907.x","article-title":"The shaping of the brain-specific T lymphocyte repertoire in the thymus","volume":"149","author":"Wekerle","year":"1996","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.crimmu.2022.03.001_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11910-016-0685-y","article-title":"Alemtuzumab for multiple sclerosis","volume":"16","author":"Willis","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.crimmu.2022.03.001_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/23287","article-title":"Continued RAG expression in late stages of B cell development and no apparent re-induction after immunizion","volume":"400","author":"Yu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.crimmu.2022.03.001_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1756285617722706","article-title":"Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world","volume":"10","author":"Ziemssen","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."}],"container-title":["Current Research in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590255522000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590255522000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:45:50Z","timestamp":1762922750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590255522000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":34,"alternative-id":["S2590255522000026"],"URL":"https:\/\/doi.org\/10.1016\/j.crimmu.2022.03.001","relation":{},"ISSN":["2590-2555"],"issn-type":[{"value":"2590-2555","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of thymic function promotes EAE relapse in anti-CD52-treated mice","name":"articletitle","label":"Article Title"},{"value":"Current Research in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crimmu.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}